Patrick Celis
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Virus-based gene therapy research
-
- Biomedical Ethics and Regulation
Papers in
-
- Pluripotent Stem Cells Research 6
- CRISPR and Genetic Engineering 5
- Viral Infectious Diseases and Gene Expression in Insects 1
- Oncology 9
- CAR-T cell therapy research 9
- Co-authors
- Christian K. Schneider (2 shared papers)Ilona Reischl (6 shared papers)Paula Salmikangas (4 shared papers)Nicolas Ferry (3 shared papers)Egbert Flory (4 shared papers)Dariusz Śladowski (2 shared papers)Martina Schuessler‐Lenz (3 shared papers)Matthias Renner (1 shared paper)
- Journals
- Advances in experimental medicine and biology (2 papers)British Journal of Clinical Pharmacology (1 paper)Human Gene Therapy (1 paper)Regenerative Medicine (1 paper)Nature Reviews Drug Discovery (1 paper)
- Partner nations
- GermanyNetherlandsUnited Kingdom
In The Last Decade
Patrick Celis
16 papers receiving 388 citations
Peers
Comparison fields: 5 of 70
- Genetics 72
- Physiology 152
- Oncology 106
- Molecular Biology 178
- Biomaterials 34
Countries citing papers authored by Patrick Celis
This map shows the geographic impact of Patrick Celis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Celis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Celis more than expected).
Fields of papers citing papers by Patrick Celis
This network shows the impact of papers produced by Patrick Celis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Celis. The network helps show where Patrick Celis may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Celis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 180 | |
| 2 | 2015 | 51 | |
| 3 | 2017 | 45 | |
| 4 | 2015 | 38 | |
| 5 | 2017 | 27 | |
| 6 | 2012 | 20 | |
| 7 | 2010 | 13 | |
| 8 | European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products. | 2004 | 10 |
| 9 | 2011 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2015 | 6 | |
| 12 | 2024 | 2 | |
| 13 | 2013 | 2 | |
| 14 | 2015 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2018 | 1 |
About Patrick Celis
Patrick Celis is a scholar working on Molecular Biology, Oncology, Physiology, Genetics and Infectious Diseases, having authored 16 papers that have together received 414 indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (9 papers), CAR-T cell therapy research (9 papers), Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers), Virus-based gene therapy research (4 papers), Biosimilars and Bioanalytical Methods (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Hepatitis Viruses Studies and Epidemiology (1 paper). The work is most often cited by research in Genetics (72 citations), Physiology (152 citations), Oncology (106 citations), Molecular Biology (178 citations) and Biomaterials (34 citations). Patrick Celis has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include Christian K. Schneider, Ilona Reischl, Paula Salmikangas, Nicolas Ferry, Egbert Flory, Dariusz Śladowski, Martina Schuessler‐Lenz, Matthias Renner, Melanie Carr and Bernd Gänsbacher. Their work appears in journals such as Advances in experimental medicine and biology, British Journal of Clinical Pharmacology, Human Gene Therapy, Regenerative Medicine and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.